Lightpath Technologies Inc (LPTH) · Nov 5, 2026 · Disposition
China divestiture closed — 100% subsidiary sale closed October 30; China third-party revenue averaged ~$4.5M annually
LightPath’s China divestiture is complete. The company gains a fully Western-aligned footprint but loses about $4.5M of annual consolidated revenue.
LightPath is completing a shift toward defense-focused, Western-aligned optics manufacturing. The company has been moving away from China-linked production while building demand around defense, public safety, infrared systems, and germanium-free optics; its fiscal 2026 results showed revenue rising to $71.7 million and backlog reaching roughly $110.9 million.
The transaction is now legally complete, but the strategic news was already public. LightPath closed the previously announced sale of 100% of its Chinese subsidiary effective October 30, converting the July agreement from a plan into an executed disposition. The company now has no China facilities or operations. 〔0〕
The business gains sourcing clarity but gives up a small revenue stream. The China operation’s third-party customer revenue averaged approximately $4.5 million annually in fiscal 2025 and 2026 and will no longer be consolidated. That is a real reduction in reported revenue, but it represents only about 6% of fiscal 2026 revenue based on the company’s reported $71.7 million total.
Supply continuity is preserved, but through a third party rather than owned capacity. LPOIZ is expected to keep supplying LightPath’s U.S. and European commercial customers under its new ownership, limiting near-term disruption. The trade-off is that LightPath must rely on the buyer to maintain operations and meet supply commitments while it expands non-China capacity for defense demand.
Bottom line: This completes an already announced strategic transition rather than changing the market’s prior understanding. It modestly reshapes reported revenue and supply-chain exposure, but the filing itself is confirmation—not a fresh change to the business story.
Capacity expansion for defense demand
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!